These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 1342969

  • 21. Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues.
    Chleq-Deschamps CM, LeBrun DP, Huie P, Besnier DP, Warnke RA, Sibley RK, Cleary ML.
    Blood; 1993 Jan 15; 81(2):293-8. PubMed ID: 8422456
    [Abstract] [Full Text] [Related]

  • 22. [Cytogenetic and molecular aspects in MALT lymphomas].
    Robledo M, Santos M, Santón A, Echezarreta G, Rivas C, Benítez J.
    Sangre (Barc); 1991 Aug 15; 36(4):295-9. PubMed ID: 1776108
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements.
    Yonetani N, Akasaka T, Akasaka H, Ohno H, Okuma M, Miura I, Takahashi N, Miyanishi S, Okumura A, Muramatsu M, Fukuhara S.
    Oncogene; 1998 Aug 27; 17(8):971-9. PubMed ID: 9747876
    [Abstract] [Full Text] [Related]

  • 25. Establishment of a human herpes virus-8-negative malignant effusion lymphoma cell line (STR-428) carrying concurrent translocations of BCL2 and c-MYC genes.
    Taira T, Nagasaki A, Tomoyose T, Miyagi J, Kakazu N, Makino S, Shinjyo T, Taira N, Masuda M, Takasu N.
    Leuk Res; 2007 Sep 27; 31(9):1285-92. PubMed ID: 17368758
    [Abstract] [Full Text] [Related]

  • 26. Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.
    Masir N, Campbell LJ, Jones M, Mason DY.
    Pathology; 2010 Apr 27; 42(3):212-6. PubMed ID: 20350212
    [Abstract] [Full Text] [Related]

  • 27. Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18)(q27;q32;q21).
    Yamamoto K, Ono K, Katayama Y, Shimoyama M, Matsui T.
    Cancer Genet Cytogenet; 2007 Nov 27; 179(1):69-75. PubMed ID: 17981218
    [Abstract] [Full Text] [Related]

  • 28. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L, Pérez-Rosado A, Artiga MJ, Camacho FI, Rodríguez A, Martínez N, Ruiz-Ballesteros E, Mollejo M, Martinez B, Cuadros M, Garcia JF, Lawler M, Piris MA.
    J Pathol; 2005 Jun 27; 206(2):123-34. PubMed ID: 15880597
    [Abstract] [Full Text] [Related]

  • 29. Translocations t(14;18) and t(8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3).
    Brito-Babapulle V, Crawford A, Khokhar T, Laffan M, Matutes E, Fairhead S, Catovsky D.
    Leukemia; 1991 Jan 27; 5(1):83-7. PubMed ID: 1999960
    [Abstract] [Full Text] [Related]

  • 30. Gene amplification of Japanese non-Hodgkin lymphoma with involvement of the BCL2 gene.
    Miyamura K, Kobayashi T, Sasaki T, Ibuka T, Imai K, Sakai Y, Kawaguchi K, Miyashita T, Iwaya M, Mizutani S.
    Int J Hematol; 1991 Apr 27; 54(2):137-40. PubMed ID: 1747446
    [Abstract] [Full Text] [Related]

  • 31. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S, Quattrone A, Schiavone N, Calastretti A, Copreni E, Bevilacqua A, Canti G, Gong L, Morelli S, Nicolin A.
    Oncogene; 1996 Jul 04; 13(1):105-15. PubMed ID: 8700536
    [Abstract] [Full Text] [Related]

  • 32. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A, Harris AW, Bath ML, Cory S.
    Nature; 1990 Nov 22; 348(6299):331-3. PubMed ID: 2250704
    [Abstract] [Full Text] [Related]

  • 33. Hodgkin cells accumulate mRNA for bcl-2.
    Hell K, Lorenzen J, Fischer R, Hansmann ML.
    Lab Invest; 1995 Oct 22; 73(4):492-6. PubMed ID: 7474920
    [Abstract] [Full Text] [Related]

  • 34. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas.
    Knezevich S, Ludkovski O, Salski C, Lestou V, Chhanabhai M, Lam W, Klasa R, Connors JM, Dyer MJ, Gascoyne RD, Horsman DE.
    Leukemia; 2005 Apr 22; 19(4):659-63. PubMed ID: 15716988
    [Abstract] [Full Text] [Related]

  • 35. Variation in BCL2 protein expression in follicular lymphomas without t(14;18) chromosomal translocations.
    Masir N, Jones M, Abdul-Rahman F, Florence CS, Mason DY.
    Pathology; 2012 Apr 22; 44(3):228-33. PubMed ID: 22406486
    [Abstract] [Full Text] [Related]

  • 36. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.
    Lee JT, Innes DJ, Williams ME.
    J Clin Invest; 1989 Nov 22; 84(5):1454-9. PubMed ID: 2509518
    [Abstract] [Full Text] [Related]

  • 37. Genomic organization of the translocations (8;14) and (14;18) in a new lymphoma cell line.
    Lambrechts AC, Dorssers LC, Hupkes PE, van Gurp R, Baumgarten R, Hagemeijer A, van 't Veer MB, Touw IP.
    Leukemia; 1994 Jul 22; 8(7):1164-71. PubMed ID: 8035608
    [Abstract] [Full Text] [Related]

  • 38. Cytogenetic, molecular biological and clinical study of B-cell lymphomas with 14;18 translocation in Japanese patients.
    Takechi M, Tanaka K, Hashimoto T, Asaoku H, Dohy H, Kikuchi M, Kamada N.
    Leukemia; 1991 Dec 22; 5(12):1069-75. PubMed ID: 1774956
    [Abstract] [Full Text] [Related]

  • 39. Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
    Nakamine H, Masih AS, Chan WC, Sanger WG, Armitage JO, Weisenburger DD.
    Leuk Lymphoma; 1993 May 22; 10(1-2):79-88. PubMed ID: 8374527
    [Abstract] [Full Text] [Related]

  • 40. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.
    Tanaka S, Louie DC, Kant JA, Reed JC.
    Blood; 1992 Jan 01; 79(1):229-37. PubMed ID: 1339299
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.